Concepedia

Renzhao Gui

RG

Statistics

Publications

4

Citations

64

H-Index

4

Active since

2022

Affiliations

Zunyi Medical University(Current)

Chinese Academy of Sciences

Shanghai Institute of Materia Medica

National Center for Drug Screening

Hangzhou First People's Hospital

Renzhao Gui is an author at Zunyi Medical University specializing in pharmacology, acute myeloid leukemia therapy, and acute leukemia chemotherapy.

Publications per year

2022–2024

4

Publications

4

Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors

Haiting Duan, Jingyu Zhang, Renzhao Gui et al. · Journal of Medicinal Chemistry · 2024 · 19 citations

, , +13

Dual inhibition of CHK1/FLT3 enhances cytotoxicity and overcomes adaptive and acquired resistance in FLT3-ITD acute myeloid leukemia

Kailong Jiang, Xuemei Li, Chang Wang et al. · Leukemia · 2022 · 18 citations

, , +16

Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia

Jingyu Zhang, Haiting Duan, Renzhao Gui et al. · European Journal of Medicinal Chemistry · 2023 · 14 citations

, , +8

Discovery of CLPP-1071 as an Exceptionally Potent and Orally Efficacious Human ClpP Activator with Strong In Vivo Antitumor Activity

Beijing Chen, Mingyang Sun, Chun Zhang et al. · Journal of Medicinal Chemistry · 2024 · 13 citations · Full text

, , +11

1–4 of 4